Jobs / United States / Regeneron Pharmaceuticals INC
Executive Director, Commercial Insights & Analytics - Ophthalmology
Regeneron Pharmaceuticals INC · 🇺🇸 SLEEPY HOLLOW
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles1 certified filing for “Executive Director Financial Planning & Analysis” (Financial Managers) in NJ: $317k–$317k, median $317k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Executive Director to lead our Commercial Insights and Analytics Ophthalmology team. The Executive Director, Commercial Insights and Analytics (I&A), Ophthalmology, will report directly into the Vice President, Commercial Strategy and Insights & Analytics (CSI&A) within the CSI&A department. This role will lead the I&A team responsible for the Ophthalmology Commercial Business Unit (CBU) to drive deeper insights that inform business decisions across some of Regeneron’s leading brands. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide. When & where: • Work Location: Sleepy Hollow, NY or Warren, NJ • 4 days per week on site Discover your role: Lead 1) Lead and mentor the CSI&A Ophthalmology team in providing business analytics, customer insights and competitive intelligence to deliver rich insights to solve key business problems 2) Set the strategic I&A direction that aligns with CBU priorities and helps drive launch excellence 3) Serve as a member of the Ophthalmology CBU Leadership Team, providing I&A expertise 4) Serve as a member of the CSI&A leadership team to drive cross-commercial innovation and best-in-class delivery Develop 5) Translate complex analyses into compelling insights and recommendations that will be used to inform business decision-making for senior Regeneron teams, including the CBU, Chief Commercial Officer, Chief Executive Officer and Board of Directors 6) Develop people from both a functional skills and leadership perspective, with the goal of growing internal talent 7) Assess and implement novel methodologies and frameworks to a) garner meaningful insights to inform brand differentiation, market growth and business impact; and b) consider business potential for pipeline products Partnership and collaboration 8) Collaborate with the Ophthalmology CBU and other members of senior leadership to contribute to ongoing brand strategies and decisions, including long-term data, analytics and insights roadmap 9) Develop and maintain a mutually beneficial partnership with CBU stakeholders; ensure insight generation and feedback are embraced; strike a balance between project rigor, timelines and ability to influence decisions 10) Lead efforts to identify and crystalize insights that inform strategic plans for the Ophthalmology CBU 11) Work with other CSI&A leads to develop standardized adoption of capabilities such as marketing mix, promotional optimization, data science, market structure analyses, patient/treatment flow modeling, analog modeling and ML/AI methodologies across I&A Execute 12) Proactively communicate with the Ophthalmology CBU and provide strategic recommendations and insights as well as anticipated future needs 13) Construct and deliver integrated business reviews, I&A summary overviews with the Ophthalmology CBU and with CSI&A leadership 14) Manage third-party vendor relationships This role requires: • 20+ years of pharmaceutical/biotech commercial experience, in roles of increasing accountability; prior experience with buy-and-bill brands in highly competitive markets is required • Minimum Bachelor’s degree in data science, public health, statistics, engineering, or a related field (MBA, MPH, MS preferred) • Functional expertise in business analytics, customer insights, analog forecast development, market access, and competitive intelligence • Prior experience managing I&A groups with responsibility for analytics, customer insights, market access analytics, and competitive intelligence • Demonstrated knowledge of the legal and reg